Biotech Week Boston 2025

Aurealis Therapeutics will be attending LSX World Congress USA, 16-17 September 2025 in Boston. This is a leading forum that brings together innovators, investors, and senior life science dealmakers to shape the future of healthcare. Representing Aurealis Therapeutics will be Juha Yrjänheikki (CEO) and Laurent Décory (COO). Our team will also present on Wednesday, 17 September at 12:45, highlighting our

Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro (Director, Pre-clinical & Pharmacology) met with investors, scientific partners, and licensing stakeholders to explore new collaboration opportunities.